Telehealth Economics for Private Medical Practices

Telehealth arrived in most practices as an emergency improvisation and has stayed as a permanent question mark. Owners know patients like it and that competitors offer it, but few have ever pinned down whether their own telehealth visits make money, lose money, or simply move revenue around. The honest answer depends almost entirely on variables that live in payer contracts and visit mix rather than in patient enthusiasm, and getting it right means treating telehealth as a service line with its own economics, not a free convenience bolted onto the existing schedule.

Reimbursement Is the Whole Ballgame

The single biggest driver of telehealth economics is how the visit is reimbursed. According to CMS and commercial payer policy, telehealth reimbursement has shifted considerably since the public health emergency, with some payers paying virtual visits at parity with in-person care and others at a reduced rate, and the rules continue to evolve. When telehealth is reimbursed near parity, the lower facility and rooming cost makes it genuinely attractive. When it is discounted, the margin narrows quickly, because the provider time the visit consumes is identical either way.

This is why the first step is never a patient survey; it is verifying current, payer-specific telehealth reimbursement across your actual mix. A practice weighted toward payers that discount virtual visits faces very different economics from one whose payers hold parity, which ties telehealth directly to payer mix and reimbursement rates. The contracts decide whether telehealth is a margin or a loss before a single virtual visit is booked.

The Real Cost and the Right Visit Mix

A telehealth visit changes the cost structure rather than eliminating it. It avoids exam-room turnover, reduces front-desk rooming, and uses fewer supplies, while adding a platform subscription, a scheduling and tech-support workflow, and provider time that is unchanged from an in-person encounter. The net cost is usually lower than an in-person visit, which is exactly why the economics improve at parity and erode at a discount. Reading those numbers requires a clear sense of your in-person cost baseline, which is why telehealth analysis sits on top of your practice overhead benchmarks.

Visit mix is the second economic lever. Follow-ups, medication management, behavioral health, chronic-disease check-ins, and non-exam triage translate cleanly to a virtual encounter, while hands-on examinations, procedures, and diagnostics do not. Matching the right visit types to telehealth raises both clinical value and margin, whereas forcing the wrong ones virtual frustrates everyone and adds little revenue. Because provider minutes are the binding constraint, the visit-mix decision connects telehealth to panel size and provider capacity: telehealth fills the schedule more efficiently, but it does not multiply how many patients a clinician can carry.

Deciding Whether to Build the Service Line

For a smaller practice, the question is whether the platform and workflow investment is justified by the reimbursement and eligible visit volume, not by general enthusiasm for virtual care. A subscription, the workflow changes, and clinician buy-in are real costs, so the case rests on the specific economics of your payer mix and your eligible visit types. The practices that model this honestly before buying avoid paying for a virtual service line that never reaches sustainable volume. Structuring that evaluation, payer mix, technology stack, workflow integration, and clinician buy-in, is exactly what the telehealth readiness assessment is built to do.

Telehealth done well also supports the broader practice economics, because the right virtual visits reduce no-shows for appropriate appointment types and fill schedule gaps that an in-person calendar could not, which connects it to patient lifetime value through better continuity and retention. Treated as a priced, deliberate service line rather than a free feature, telehealth becomes one more lever in the operator toolkit mapped on the healthcare lead generation hub.

Putting a Number on the No-Show Effect

The clearest economic benefit of telehealth is one that rarely shows up in the reimbursement debate: it lowers the no-show rate for the visit types that fit it. A patient who would skip an in-person follow-up because of work, childcare, or transportation can often keep a virtual one from a phone or a parked car. That matters because the MGMA benchmark for primary care no-shows sits in the range of 5% to 7%, and every percentage point above that is schedule capacity the practice has already staffed and cannot recover. The economics of that leak are laid out in the true cost of patient no-shows, and telehealth is one of the few levers that addresses the root cause rather than the symptom.

Consider a behavioral health or chronic-care panel where roughly one in eight scheduled follow-ups historically failed to show. Moving the appropriate share of those visits virtual, where the friction to attend is far lower, can recover a meaningful fraction of that lost capacity without adding a single provider hour. The honest version of this calculation pairs the recovered visits against the platform and workflow cost rather than assuming the no-show reduction is free margin. Where the recovered, reimbursed visits exceed the cost of running the service line, telehealth pays for itself on attendance alone, before any parity argument is settled.

The Rules That Quietly Govern the Economics

Beyond the headline parity question, several coverage details decide whether a given telehealth visit is billable at all, and missing them turns an expected payment into a write-off. Audio-only coverage is the clearest example: some payers reimburse a telephone-only encounter and others require two-way audio and video, so a practice that defaults to phone for convenience can render a visit non-billable under the wrong plan. According to CMS policy, the rules governing originating site, eligible visit types, and audio-only coverage have moved repeatedly since the public health emergency, which is why a practice cannot set its telehealth billing logic once and leave it.

The operational defense is a payer-by-payer telehealth coverage grid that the billing team keeps current: which plans pay, at what rate, for which modality, and for which place-of-service and modifier combination. This is the same discipline that protects the rest of the revenue cycle, which is why telehealth billing accuracy connects directly to days in AR and the revenue cycle. A virtual visit denied for a coding or modality error is not lower-margin telehealth, it is unpaid telehealth, and the denial ages the receivable exactly like any other.

The Hybrid Schedule Is the Real Design Question

The practices that get the most from telehealth rarely run it as a separate clinic. They blend virtual and in-person slots into a single provider schedule so the clinician can flip between encounter types without the dead time of a fully segregated virtual block that may not fill. A common pattern is to anchor telehealth in the parts of the day that historically ran light, early mornings or late afternoons, and to reserve them for the follow-up, medication-management, and behavioral-health visits that translate cleanly to a screen.

Designing that hybrid schedule is fundamentally a capacity question, not a technology one, which is why it sits on top of panel size and provider capacity. The goal is to use virtual visits to raise the density and continuity of the existing panel, not to chase incremental volume the practice cannot clinically support. A provider already at a healthy panel uses telehealth to serve that panel more efficiently. A provider with room uses it to improve access and reduce the leakage that erodes patient lifetime value when patients cannot get a timely appointment.

Why the Policy Backdrop Keeps Shifting

The reason telehealth economics demand annual review rather than a one-time decision is that the policy floor underneath them keeps moving. The pandemic-era flexibilities that made telehealth nearly universal were temporary extensions, and according to MedPAC analysis and CMS rulemaking, the question of which flexibilities become permanent has been revisited repeatedly rather than settled in a single stroke. A practice that built its virtual service line on an assumption that quietly expired can find itself delivering visits that no longer pay the way the original model assumed.

The practical discipline is to treat telehealth like any other contracted service line and re-verify its economics on the same cadence a practice would review its commercial contracts, which ties it directly to payer mix and reimbursement rates. The owners who keep a current read on coverage and rate are the ones positioned to expand virtual visits when the policy supports it and to pull back the modalities that stop paying, rather than discovering the change in a denial report months later.

A Worked Example: Telehealth's No-Show Recovery in Numbers

The attendance argument is easy to assert and harder to size, so put it on one schedule. Take a primary-care practice running 1,000 visits a month. At the MGMA benchmark for primary-care no-shows of 5% to 7%, that practice is losing between 50 and 70 already-staffed visits every month to patients who simply do not show, with the midpoint of the MGMA range, 6%, putting the figure at 60 missed visits. Those slots were rooms held, staff scheduled, and provider time reserved, and they recover nothing once the hour passes. That 50-to-70-visit band is the size of the prize telehealth is competing for.

Now isolate the visits telehealth can actually reach. Suppose 200 of those 1,000 monthly visits are the follow-up, behavioral-health, and chronic-care check-ins that translate cleanly to a screen. As this article notes, a panel of those visit types can historically run a no-show rate of roughly one in eight, which on 200 visits is about 25 missed appointments a month, a rate well above the MGMA 5% to 7% band precisely because these are the visits patients skip when work, childcare, or transportation gets in the way. That gap between one-in-eight and the MGMA range is not a clinical problem; it is a friction problem, and friction is what a virtual visit removes.

Move the appropriate share of those 200 visits virtual and the friction drops. If the telehealth versions attend at the MGMA midpoint of 6%, only about 12 of the 200 would fail to show, down from 25, recovering roughly 13 visits a month that were previously lost, without adding a single provider hour. Thirteen recovered, reimbursed visits a month is the concrete return that has to be weighed against the platform subscription and the workflow cost of running the service line. The honest test, exactly as the reimbursement section argued, is whether those recovered visits pay enough under your contracts to clear that cost.

Notice what this example does and does not claim. It does not assert telehealth conjures new demand; the 200 eligible visits were already on the books. It simply converts a slice of the practice's existing no-show loss, sized by the MGMA benchmark, into kept appointments by lowering the friction to attend. That is why the attendance benefit is the most defensible line in the entire telehealth business case: it does not depend on winning the parity argument or finding incremental patients, only on the well-documented fact that virtual visits are easier to keep. Where reimbursement holds near parity, those recovered visits are close to pure additional margin on capacity the practice was already paying for.

A Simple Decision Framework

For an owner weighing whether to launch or expand telehealth, the decision reduces to three sequential questions, asked in order. First, do your dominant payers reimburse the visit types you would move virtual at a rate that covers the provider time. If the answer is no across your largest payers, the service line starts underwater and no volume fixes that. Second, do you have enough eligible visit volume, the follow-ups, behavioral-health, and chronic-care check-ins, to fill the virtual slots you would create. A platform paid for and half-used is overhead, not a service line.

Third, and only after the first two clear, can your workflow and your clinicians actually absorb the change without degrading the in-person schedule that still pays the bills. A practice that answers yes to all three has a genuine margin opportunity. A practice that forces the launch despite a no on any of them has bought a liability wearing the costume of an opportunity. Running that sequence honestly, against your own numbers, is exactly what the telehealth readiness assessment structures.